top of page
WayMaker Screens multi view.png
WM short logo.png

+

Choice PharmD logo large.png

Real Pharmacists

For Personalized Care

  • PharmD over-reads on PCR lab results are crucial in today's healthcare landscape, especially for antimicrobial stewardship.

​

  • Our reports provide detailed and accurate considerations of lab results, aiding healthcare providers in selecting the most appropriate antimicrobial therapies.

​

  • By ensuring treatments are both effective and targeted, PharmD reports help reduce the misuse of antibiotics.

​

  • Reducing antibiotic misuse is a key component of antimicrobial stewardship.

​

  • This is particularly important now, as antibiotic-resistant pathogens are a growing threat to public health.

​

  • PharmD considerations ensure that treatments align with best practices, minimizing the development of resistance.

​

  • The use of our PharmD report and the treatment considerations can improve outcomes by promoting appropriate and effective antimicrobial use.

Why is PharmD

So Important?

At WayMaker, we prioritize human expertise at every step of the process.
Each positive result is carefully reviewed by a licensed pharmacist from our PharmD partner. They assess patient allergies (when provided), antibiotic resistance, and other relevant clinical factors to provide personalized treatment considerations. This approach ensures clinicians receive meaningful insights that support informed decisions and help improve patient outcomes with precision and care.

Why Antibiotic Stewardship Matters

Most upper respiratory tract infections (URTIs) are caused by viruses and are best managed with supportive care. Unfortunately, antibiotics are often overprescribed, leading to unnecessary side effects and contributing to the growing threat of antimicrobial resistance.

This is where Choice PharmD plays a critical role in antibiotic stewardship. By providing a detailed report that identifies pathogens, resistance genes, and clinically relevant treatment options, Choice PharmD equips providers with the data they need to make informed decisions. This ensures antibiotics are only prescribed when necessary and with the most appropriate options for the patient.

Integrated with WayMaker's software, providers gain seamless access to labs that deliver timely, accurate results. Together, WayMaker and Choice PharmD simplify lab selection and ensure that actionable insights—like those in the Choice PharmD report—can be effectively utilized to improve patient care, reduce antimicrobial misuse, and enhance outpatient treatment strategies.

Bridging Molecular Diagnostics with Stewardship

WayMaker exclusively partners with Choice PharmD. Choice PharmD is a laboratory consulting firm that exists to support providers in applying therapeutic considerations to molecular diagnostics.
 
Detected pathogens and resistance genes are considered in conjunction with patient-specific characteristics to provide healthcare practitioners with considerations for treatment regimens. Medication selection, dosages, and durations are in congruence with clinical practice guidelines (IDSA, CDC, AAP,
etc). Our PharmD reports detail which medications provide antimicrobial coverage for specific detected pathogens, making samples with multiple detected pathogens simpler to navigate and determine treatment for providers. Antimicrobial resistance is a growing concern in healthcare and judicious selection of antimicrobials is crucial for patient-centered care and to prevent a worsening healthcare crisis. Our pharmacists specialize in the interpretation and clinical application of detected resistance genes. Choice PharmD’s top priority is to provide healthcare professionals with accurate, high-level treatment considerations, resulting in targeted therapy for patient-centered care.

bottom of page